Toshiba Introduces New Applications Taking CT from Anatomical to Functional

CHICAGO–(BUSINESS WIRE)–Toshiba America Medical
Systems, Inc. announces new functional-based clinical applications – Dual
Energy and Myocardial Perfusion (both works-in-progress), as well as Body
Perfusion – for its AquilionTM CT
systems. These applications are shown at this years Radiological Society of
North America (RSNA) annual meeting in Chicago,
Nov. 27 – Dec. 2, 2011 (Booth #5634, South Hall).

Dual Energy (WIP)

Dual Energy, which will be available on Aquilion ONETM, Aquilion Premium and
Aquilion PRIME (pending 510(k) clearance), uses two energy levels to increase
the amount of information available from CT imaging. It can non-invasively help
to visualize and characterize anatomy. Toshibas unique Dual Energy changes kV
and mA during a single scan and deactivates the X-ray at the anterior section
of the body to reduce overall radiation dose to sensitive areas.

Myocardial Perfusion (WIP)

With Toshibas Aquilion ONE, a combination of CTA and CT myocardial perfusion
can be utilized to visualize blood flow and more precisely identify ischemia
with less radiation than PET/CT and/or SPECT imaging. To validate this clinical
application for CT, the multi-center, Toshiba-supported CORE320 trial completed
enrollment in September and aims to compare the accuracy of CTA and CT
myocardial perfusion to SPECT and Catheter Angiography.

Body Perfusion

Toshibas Body Perfusion is an application to evaluate perfusion of the target
organ or target lesions with dynamic volume imaging of entire organs during
contrast medium infusion. This can provide invaluable information in the
diagnosis of disease and for assessing the effectiveness of treatment. Once
combined with Toshibas AIDR 3D (pending 510(k) clearance) algorithm, Body
Perfusion enables clinicians to perform body perfusion exams using lower dose,
making it safer for the patient. It will be available for Aquilion ONE and
Aquilion Premium.

“Technology advancements continue to take CT from anatomical
to physiological, showing blood flow and function,” said Joseph Cooper,
director, CT Business Unit, Toshiba. “Our new clinical CT applications enable
clinicians to evaluate disease more easily, with the potential to dramatically
improve patient care.”

About Toshiba America Medical Systems, Inc.

With headquarters in Tustin, Calif.,
Toshiba America Medical Systems (TAMS) markets, sells, distributes and services
diagnostic imaging systems, and coordinates clinical diagnostic imaging
research for all modalities in the United States. For more
information, visit the TAMS website at www.medical.toshiba.com.

About Toshiba Medical Systems Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical
diagnostic imaging systems and comprehensive medical solutions, such as CT,
X-ray and vascular, ultrasound, nuclear medicine, and MRI systems, as well as
information systems for medical institutions. Toshiba Medical Systems
Corporation has been providing medical products for over 80 years. Toshiba
Medical Systems Corporation is a wholly owned subsidiary of Toshiba.

About Toshiba

Toshiba is a diversified manufacturer and marketer of advanced electronic and
electrical products, spanning digital products, such as LCD TVs, notebook
PCs and hard disc drives; electronic devices and components, such as
semiconductors; social infrastructure systems, including power generation
systems, and home appliances. Toshiba was founded in 1875, and today operates a
global network of more than 490 companies, with 203,000 employees worldwide and
annual sales surpassing 6.3 trillion yen (US$77 billion).

Posted by Sean Fenske, Editor-in-Chief, MDT